ENTITY
Ensysce Biosciences

Ensysce Biosciences (ENSC US)

22
Analysis
Health Care • United States
Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.
more
bullish•Ensysce Biosciences
•15 Aug 2026 01:00•Issuer-paid

ENSC: Entering Pivotal Stage in Good Shape

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•08 Aug 2026 18:50

Primer: Ensysce Biosciences (ENSC US) - Aug 2026

Ensysce Biosciences is a clinical-stage pharmaceutical company developing a new class of abuse-deterrent and overdose-resistant opioids,...

Share
bullish•Ensysce Biosciences
•07 Aug 2026 00:00•Issuer-paid

ENSC: Strategic Acquisition Bolsters Pipeline

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•15 Jul 2026 00:00•Issuer-paid

ENSC: Funding Boost Received

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•19 May 2026 00:00•Issuer-paid

ENSC: Building Momentum Toward Commercialization

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
x